While not FDA-approved for performance enhancement, its used in supervised medical protocols for body composition and metabolic optimization
The particle size and polydispersity index (PDI) were determined daily using dynamic light scattering
Also on Merseyside, the BBC was able to buy a "quadruple strength" spray on offer for 20, with the reporter advised to use it morning and night
Common injection sites include the abdomen (at least 2 inches from the navel), the front of the thighs, and the back of the upper arms (if someone else is administering)
KKF, a source for health policy research, polling and news, in May 2024 released a poll that found 12% of adults said they had taken a GLP-1 agonist, with 6% saying they currently take the drug